Labcorp Holdings (LH) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/30/26
Labcorp (LH) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 07/29/26
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk TestingPRNewsWire • 07/27/26
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 07/24/26
Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?Zacks Investment Research • 07/24/26
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/21/26
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening TestPRNewsWire • 06/22/26
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-TermZacks Investment Research • 06/08/26
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/03/26
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?Zacks Investment Research • 06/01/26
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal CancerPRNewsWire • 05/29/26
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side EffectsPRNewsWire • 05/28/26